SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease ...
We searched different electronic databases for relevant studies with a cut-off date of 29 February 2008, including the Cochrane Controlled Trials Register on the Cochrane Library, Issue 1, 2008, ...
Researchers have found that that a mutant strain of sake yeast produces high levels of the amino acid ornithine. Ornithine has been found to reduce fatigue and improve sleep quality, and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results